Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial

AIM: This is the first randomised study to evaluate toxicity and survival outcomes of two neoadjuvant chemoradiotherapy (CRT) regimens for patients with localised oesophageal adenocarcinoma (OAC) or gastro-oesophageal junction (GOJ) adenocarcinoma. The initial results showed comparable toxicity betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, Somnath, Hurt, Christopher, Radhakrishna, Ganesh, Gwynne, Sarah, Bateman, Andrew, Gollins, Simon, Hawkins, Maria A., Canham, Joanne, Grabsch, Heike I., Falk, Stephen, Sharma, Ricky A., Ray, Ruby, Roy, Rajarshi, Cox, Catrin, Maynard, Nick, Nixon, Lisette, Sebag-Montefiore, David J., Maughan, Timothy, Griffiths, Gareth O., Crosby, Tom D.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330696/
https://www.ncbi.nlm.nih.gov/pubmed/34157617
http://dx.doi.org/10.1016/j.ejca.2021.05.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330696/
https://www.ncbi.nlm.nih.gov/pubmed/34157617
http://dx.doi.org/10.1016/j.ejca.2021.05.020

Ejemplares similares